CRINETICS PHARMACEUTICALS INC. - COMMON STOCK

Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement

28 2月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

14 2月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces February 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 2月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces January 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 1月 2024 16:33:42 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

03 1月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Crinetics Announces Positive Initial Findings from Ongoing Open-Label Phase 2 Study of Paltusotine for the Treatment of Carcinoid Syndrome

18 12月 2023 16:05:00 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces December 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 12月 2023 16:05:00 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in Upcoming Investor Conferences

20 11月 2023 16:05:00 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 11月 2023 17:00:00 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

07 11月 2023 16:05:00 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 10月 2023 17:00:00 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in the Cantor Global Healthcare Conference 2023

20 9月 2023 08:00:00 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

12 9月 2023 22:26:42 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

11 9月 2023 16:01:22 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 9月 2023 06:00:48 条件 Nasdaq GlobeNewswire

Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-1 Study Evaluating Treatment of Patients with Acromegaly

10 9月 2023 10:00:04 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 8月 2023 17:34:32 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

08 8月 2023 07:00:01 条件 Nasdaq GlobeNewswire

Crinetics Hosting Key Opinion Leader Webinar to Discuss the Current Treatment Landscape and Unmet Need in Acromegaly

31 7月 2023 08:01:44 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 7月 2023 16:19:04 条件 Nasdaq GlobeNewswire